Indaptus Therapeutics FY EPS $(1.83) Beats $(1.95) Estimate; Cash Balance Of $13.4M Will Provide Runway Through Q3 Of 2024
Indaptus Therapeutics FY EPS $(1.83) Beats $(1.95) Estimate; Cash Balance Of $13.4M Will Provide Runway Through Q3 Of 2024
Indaptus Therapeutics財年每股收益美元（1.83美元）超過預期（1.95美元）；1340萬美元的現金餘額將爲2024年第三季度提供資金支持
Indaptus Therapeutics (NASDAQ:INDP) reported quarterly losses of $(1.83) per share which beat the analyst consensus estimate of $(1.95) by 6.15 percent. This is a 5.78 percent decrease over losses of $(1.73) per share from the same period last year.
Indaptus Therapeutics（納斯達克股票代碼：INDP）公佈的季度虧損爲每股1.83美元，比分析師共識估計的美元（1.95美元）高出6.15％。這比去年同期每股虧損1.73美元（1.73美元）下降了5.78％。